Identification of the Profile of the Patients With Hemophilia B Eligible for Treatment With Nonacog Alfa Once-Weekly

Reports — Medical Cases, Images, and Videos
doi 10.3390/reports3010003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Treatment Responses With Once-Weekly Teriparatide Therapy for Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2016English

Postmarketing Safety and Effectiveness of Recombinant Factor IX (Nonacog Alfa) in Japanese Patients With Haemophilia B

Haemophilia
MedicineGeneticsHematology
2019English

Exenatide Extended-Release: A Once Weekly Treatment for Patients With Type 2 Diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2014English

Difficulties in the Treatment of an Infant With Hemophilia B

Turk Pediatri Arsivi
Child HealthPediatricsPerinatology
2016English

Exenatide Once-Weekly Injection for the Treatment of Type 2 Diabetes in Chinese Patients: Current Perspectives

Therapeutics and Clinical Risk Management
2015English

Study of Twice-Weekly Injections of Teriparatide by Comparing Efficacy With Once-Weekly Injections in Osteoporosis Patients: The TWICE Study

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2019English

Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia a Patients: The Role of Octocog Alfa

Farmeconomia. Health economics and therapeutic pathways
2020English

Assessment of the Upper Respiratory Tract in Patients Eligible for Treatment With Transverse Maxillary Expansion

Forum Ortodontyczne
Orthodontics
2018English

New Simulation Model for Bone Formation Markers in Osteoporosis Patients Treated With Once-Weekly Teriparatide

Bone Research
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy